Abstract

Pseudomyxoma peritonei is usually a benign tumor that is slightly more common in women. However, it requires aggressive surgical treatment and chemotherapy, often compromising future reproductive function. This report presents a case of pregnancy in a 35-year-old woman who underwent cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for treatment of pseudomyxoma peritonei. The tumor was diagnosed during a laparoscopic examination on a workup for infertility in 2008. Two months later, she underwent a peritonectomy followed by hyperthermic intraperitoneal chemotherapy and, regarding her will to conceive, ovaries and fallopian tubes were preserved. In March 2011, she went through an in vitro fertilization followed by an uneventful pregnancy and delivered a healthy child 39 weeks later. Ovaries are usually resected during the cytoreductive surgery, since they are common sites for neoplastic implants, and, even when not performed, little is known about the effects of local chemotherapy on female fertility. The largest international survey on this matter only describes seven similar cases. This particular report not only describes a rare condition but also adds to the upcoming discussion about whether ovaries can be preserved in specific situations, therefore keeping the prospect of conceiving after this treatment.

Highlights

  • Pseudomyxoma peritonei (PMP) is a rare clinical condition characterized by mucinous ascites due to the growth of a tumor on the peritoneal surface

  • PMP usually develops from primary appendiceal epithelial neoplasms, which leads to its own lumen obstruction and subsequent perforation

  • A more effective treatment was described by Sugarbaker and consists of cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) [5]

Read more

Summary

Introduction

Pseudomyxoma peritonei (PMP) is a rare clinical condition characterized by mucinous ascites due to the growth of a tumor on the peritoneal surface. The classical PMP treatment is surgical debulking of the tumor in order to alleviate the effects of abdominal pressure. It is a palliative treatment and has an increased probability of leaving the remaining neoplastic cells in the peritoneal cavity. A more effective treatment was described by Sugarbaker and consists of cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) [5]. The aim of this strategy is to resect visible disease and eliminate any occult neoplastic cells with a high concentration of chemotherapy drugs at 41-42 degrees Celsius. We report here the case of a 35-year-old woman diagnosed with PMP and submitted to CRS and HIPEC that conceived a healthy child 3 years after surgery

Case Presentation
Findings
Discussion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call